TDOCNYSEServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31

Teladoc Health, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026

$5.73+0.06 (+1.06%)

Close on Oct 19, 2026

Market cap: $1.04B
P/E (TTM): –
Dividend yield: –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Teladoc Health reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Bond issues

Individual notes and bonds outstanding

Bond-level data is not connected yet

Coupon, maturity and amount of each note will come from the debt footnote in Teladoc Health's annual report. Trading prices and yields need FINRA TRACE data.

Where these numbers come from

Parsed from the XBRL in Teladoc Health's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is TDOC.

Revenue growth-2.1% · median 3.8%

Gross margin69.0% · median 71.9%

Operating margin-7.5% · median -6.0%

Net margin-7.1% · median 0.1%

Company	Revenue	Growth
HIMS	$2.58B	+28.0%
TDOC	$2.49B	-2.1%
SBC	$175.17M	-6.9%
LFMD	$164.70M	+3.8%
AUNA	–	–
CCM	–	–

Company

Exchange: NYSE
Industry: Services-Offices & Clinics of Doctors of Medicine
Fiscal year ends: December 31
Employees: 5,600
Held by institutions: 83.9%
Auditor: Ernst & Young LLP
SEC CIK: 1477449

Advertisement
300 × 250